In the BioHarmony Drug Report Database

"Preview" Icon

Bivalirudin

Angiomax, Angiomax Rtu, Bivalirudin (bivalirudin) is a protein pharmaceutical. Bivalirudin was first approved as Angiomax on 2000-12-15. It is used to treat unstable angina in the USA. The pharmaceutical is active against prothrombin. Angiomax’s patent is valid until 2028-07-27 (FDA).

 

Trade Name

 

Angiomax, Angiomax Rtu, Bivalirudin
 

Common Name

 

bivalirudin
 

ChEMBL ID

 

CHEMBL2103749
 

Indication

 

unstable angina
 

Drug Class

 

Anticoagulants (hirudin type)

Image (chem structure or protein)

Bivalirudin structure rendering